News

The Phase Ib trial evaluating IMO-2055 is being conducted in patients with advanced or metastatic non-small cell lung cancer (NSCLC) who have progressed on first line chemotherapy. The

Veregen is reported to be the first botanical drug approved for prescription use in the US and is patented through 2017, with additional applications pending which, if approved,

The Phase II trial, which enrolled 225 subjects, is a randomized, double-blind, placebo controlled trial evaluating the safety and efficacy of BGC20-0582 in subjects infested with head lice.

Mevacor is a prescription medicine that is approved in the US for the treatment of elevated cholesterol levels that lifestyle changes alone cannot control and to reduce the

Under the terms of the agreement, FMC will apply its technology to Pronova BioPharma’s products while Pronova BioPharma will be responsible for the clinical development and for securing

As a result of the selection, Healive is one of two inactivated hepatitis A vaccines in pre-filled syringes that will be purchased by the Beijing Centers For Diseases

Based on favorable safety data in this 14-dose trial with 18 subjects (12 treated with Nov-205 and six with placebo), Novelos plans to initiate a longer proof-of-concept trial

The study enrolled 90 patients at eight primary sites in the US and Europe. Participants received either Myozyme or a placebo every other week for 18 months. The

In this study, investigators used Nutrition 21’s proprietary chromium picolinate found in Core4Life Advanced Memory Formula, a nutritional supplement specifically formulated to improve brain health. Study participants were